Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2023

Filter by date:

Showing 1239 press releases before 2023

ONGLYZA™ US label update provides further evidence regarding use in renally impaired adults with type 2 diabetes
23 February 2011
AstraZeneca and Targacept initiate phase IIB clinical trial of TC-5214 as a switch monotherapy treatment for major depressive disorder
7 February 2011
AstraZeneca halts phase III trial of ZIBOTENTAN in non-metastatic castrate resistant prostate cancer
7 February 2011
US FDA assigns new PDUFA date for BRILINTA (ticagrelor tablets)
4 February 2011
European Commission approves nasal spray vaccine FLUENZ for the prevention of seasonal influenza in children
1 February 2011
AstraZeneca PLC Fourth Quarter and Full Year Results 2010
27 January 2011
AstraZeneca Replies To The US FDA Complete Response Letter For BRILINTA (Ticagrelor Tablets)
21 January 2011
US Food and Drug Administration extend review timeline for vandetanib new drug application
7 January 2011
AstraZeneca and Abbott end license agreement for the development of Certriad
22 December 2010
AstraZeneca discontinues development of motavizumab for RSV prophylaxis indication
21 December 2010

<
1
2
3
124
>

All of our latest press releases and articles are available to explore